StockData
Gain Therapeutics, Inc. logo

Gain Therapeutics, Inc. (GANX) stock

GANXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$1.11−0.07 (-5.93%)

Close on Nov 18, 2026Market cap $48.44MP/E –Yield –

Gain Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Gain Therapeutics's price to sales ratio was 495.8× on Nov 30, 2023, against 194.6× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Nov 30, 2023495.8×+292.9
2022Dec 30, 2022202.9×−289.8
2021Dec 31, 2021492.7×–

More Gain Therapeutics figures

See a number that looks wrong?